Redx Pharma PLC (FRA:0RX)
€ 0.167 0 (0%) Market Cap: 64.96 Mil Enterprise Value: 64.48 Mil PE Ratio: 0 PB Ratio: 15.00 GF Score: 33/100

Preliminary Q4 2021 Redx Pharma PLC Earnings Call Transcript

Jan 27, 2022 / 01:00PM GMT
Release Date Price: €0.91 (-3.19%)
Operator

(technical difficulty) I'd like to advise all parties this conference is being recorded. I will now hand it over to Rachel Curtis Gravesen to open the call.

Rachel Curtis Gravesen
FTI Consulting, Inc. - IR

Hello, and welcome, and thank you so much for joining us for today's call to discuss Redx's full year results for the year ended September 30, 2021. In a moment, I'm going to hand over to Redx's Chief Executive Officer, Lisa Anson, who'll be joined by Chief Financial Officer, Peter Collum, and also Chief Scientific Officer, Richard Armer, who are going to present the progress made during this year by the company.

After the presentation, we will hold a question-and-answer session. And we'll be joined by Dr. Jane Robertson, the company's CMO, who's going to participate in that session together with the other presenters that we've just named. (Operator Instructions)

Please, let's move to the next slide. Importantly, I'd like to say before we begin that I want to draw your attention to the disclaimer slide that we have in front of you here and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot